戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  incomplete data and/or availability of only first-degree relatives).
2 and a family history of PCOS in at least one first degree relative.
3 syndrome (51%) reported a CRC diagnosis in a first-degree relative.
4 were enrolled, 69% of whom had 1 AD-affected first-degree relative.
5 ily history of sudden unexplained death in a first-degree relative.
6        Thirty-seven (70%) of the donors were first-degree relative.
7 orted a positive family history of FEVR in a first-degree relative.
8 en 1994 and 2017 after diagnosis of HCM in a first-degree relative.
9 static location depending on cancer in their first degree relatives.
10 y improve risk assessment among their female first-degree relatives.
11  individuals with bipolar disorder and their first-degree relatives.
12 bility to schizophrenia by including healthy first-degree relatives.
13 re independent of a family history of VTE in first-degree relatives.
14 ychiatric symptom information for additional first-degree relatives.
15  incomplete data and/or availability of only first-degree relatives.
16 er I with psychosis probands (BDP) and their first-degree relatives.
17 sychotic disorder probands, and 300 of their first-degree relatives.
18 DD), 110 orthopedic controls, and 1734 adult first-degree relatives.
19 d between ADHD probands and their unaffected first-degree relatives.
20 ing and their 2082 adult living and deceased first-degree relatives.
21 e ratios (SIRs) for different cancers in the first-degree relatives.
22 nancy-related factors and deaths of mothers' first-degree relatives.
23  no history of neurodegenerative disorder in first-degree relatives.
24  be comparable to phenotypic correlations in first-degree relatives.
25  showing a ~ 8-fold increased risk of CLL in first-degree relatives.
26  is associated with its increased risk among first-degree relatives.
27 = 201 healthy controls and n = 20 unaffected first-degree relatives.
28 , and 72 controls without NAFLD and their 72 first-degree relatives.
29 be without evidence of NAFLD and 69 of their first-degree relatives.
30 t of 26 probands with NAFLD-cirrhosis and 39 first-degree relatives.
31  for CRC in both groups, as well as in their first-degree relatives.
32 entive screening and surveillance in at-risk first-degree relatives.
33              There had been 123 VTEs in 2617 first-degree relatives (0.12 per 100 person-years).
34 tients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, an
35 L was found for those with multiple affected first-degree relatives (13-fold; 95% CI, 2.8- to 39-fold
36  psychotic bipolar I disorder), 369 of their first-degree relatives (134 were relatives of individual
37 4 probands with NAFLD-cirrhosis and their 72 first-degree relatives, 24 probands with NAFLD without a
38 ed beyond first-degree relatives versus only first-degree relatives (3.65 versus 0.80), used active s
39             In the per-protocol analysis, 28 first-degree relatives (3.9%) in the FIT group and 43 (5
40 earest affected relative was almost always a first-degree relative (37 of 39, 95%).
41 M) by vitiligo recurrence among a total 8034 first-degree relatives (3776 siblings, 4258 parents or o
42 l testing would be considered for those with first-degree relatives (42 [72%] of 58; 95% CI, 59.8%-82
43 m buccal smears from 63 patients with BD, 74 first-degree relatives (49 relatives had no lifetime psy
44 io (LMR) at recruitment in 1420 asymptomatic first-degree relatives (6-35 years old) of patients with
45                 Of all eligible asymptomatic first-degree relatives, 782 were included in the colonos
46 site testing the POCT was positive in 12/148 first-degree relatives (8%) and all these subjects were
47                                           In first-degree relatives, ACPA reactivity was assessed, an
48 of patients having newly diagnosed AF with a first-degree relative affected by AF between 2000 and 20
49                    Patients having AF with a first-degree relative affected by AF did not have more M
50                           Individuals with a first-degree relative affected by AF had a relative risk
51 9 [9.2] years) had newly diagnosed AF with a first-degree relative affected by AF.
52  highest among young women (< 45 years) with first-degree relatives affected at young ages (< 45 year
53 of CRC or a documented advanced adenoma in a first-degree relative age <60 years or 2 first-degree re
54 ) had a family history of breast cancer in a first-degree relative age 50 years or younger, and 363 (
55 -1.43), and were related to their recipient (first-degree relative: aIRR, 1.28; 95% CI, 1.08-1.52; sp
56 gated with disease in all available affected first-degree relatives, although four asymptomatic paren
57 ar disorder (BD)), 315 of their nonpsychotic first-degree relatives and 202 healthy controls.
58   Fifty-seven percent of anti-CCP-2-positive first-degree relatives and 8% of anti-CCP-2- negative fi
59  absent from the anergic compartment of some first-degree relatives and all prediabetic and new-onset
60 efficiently incorporating information beyond first-degree relatives and allows for the inclusion of c
61 who had SRCC reported no diagnoses of DGC in first-degree relatives and did not meet established crit
62 es is significant and higher when focused on first-degree relatives and on conditions usually express
63                                    Patients' first-degree relatives and pairwise age- and sex-matched
64 ily histories of single or multiple affected first-degree relatives and their diagnostic ages.
65 olar spectrum, particularly among unaffected first-degree relatives and those with milder expressions
66 8 patients with schizophrenia, 37 unaffected first-degree relatives, and 139 healthy controls, we det
67 omprising 20 adults with ADHD, 20 unaffected first-degree relatives, and 20 typically developing cont
68 st-episode psychosis, 25 of their unaffected first-degree relatives, and 26 healthy control subjects
69 psychotic bipolar I disorder, 1,055 of their first-degree relatives, and 459 healthy comparison subje
70 wed documented presence or absence of CFH in first-degree relatives, and 61.5% of medical records doc
71 NAFLD without advanced fibrosis and their 24 first-degree relatives, and 72 controls without NAFLD an
72  (HP), schizophrenia probands (SZ) and their first-degree relatives, and bipolar disorder I with psyc
73  patients with NLPHL, identified their 4,280 first-degree relatives, and calculated the registry-base
74 bands with psychotic bipolar disorder, their first-degree relatives, and healthy comparison subjects.
75                                              First-degree relatives, and second-degree relatives of a
76  young age and unprovoked VTE predict VTE in first-degree relatives, and that the influence of these
77  group of adults with ADHD, their unaffected first-degree relatives, and typically developing control
78 r (PBD), and schizoaffective disorder; their first-degree relatives; and healthy control subjects.
79 hat relatives of celiac patients, especially first degree relatives are at high risk of developing ce
80 ion in psychotic disorder patients and their first-degree relatives as a possible endophenotype.
81 he entire spectrum of NAFLD and 105 of their first-degree relatives, assessed by advanced magnetic-re
82                                              First-degree relatives at similar genetic distances (eg,
83 The highest familial risk was observed among first-degree relatives (attempted suicide: OR = 2.42 [95
84                 Despite high heritability in first-degree relatives, AV genetic determinants remain i
85  cancer history (FCH) is often collected for first-degree relatives, but more extensive FCH informati
86                       In patients lacking CD first-degree relatives, carriage of HLA-DQ2.5 with doubl
87 tisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number g
88  suspected antibiotic exposure, personal and first-degree relatives' comorbidities, and history of at
89 al activation or connectivity alterations in first-degree relatives compared with healthy controls, s
90                        Persons with a single first-degree relative diagnosed at >/=60 years with CRC
91 so refines the risk assessment of women with first-degree relatives diagnosed with breast cancer, par
92 ancer in families with increasing numbers of first-degree relatives diagnosed with melanoma, includin
93                                       If the first-degree relative died aged <35 years, the rate of c
94 perly in the group of patients with affected first-degree relatives due to the small sample size.
95 c mutation carriers) or were healthy at-risk first-degree relatives (either presymptomatic mutation c
96 ertained cohorts, replacing cases with their first-degree relatives enables studies of diseases that
97 orrelation coefficient, 0.73 in NF1-affected first-degree relatives) exceeded that observed in the ge
98                              Subjects with 1 first degree relative (FDR) with CRC (n = 238; HR, 1.23;
99 e quantified the risk of CRC and adenomas in first-degree relatives (FDRs) and second-degree relative
100  differentiate autoantibody-positive at-risk first-degree relatives (FDRs) from autoantibody-negative
101 cts differed from those of autoantibody-free first-degree relatives (FDRs) in the abundance of four t
102 atients combined with including or excluding first-degree relatives (FDRs) or different conditional l
103 ividuals based on age and number of affected first-degree relatives (FDRs) using data from publicatio
104 ing number of melanomas in either 1 or >/= 2 first-degree relatives (FDRs).
105 c counseling was observed more frequently in first-degree relatives, female relatives, primary arrhyt
106                  The 205 previously negative first degree relatives from Group II that underwent new
107                       It has recruited 2,632 first-degree relatives from across the USA.
108              WES was performed in 2 affected first-degree relatives from each family.
109 dent AF patients with vs without an affected first-degree relative had similar MACE-free survival.
110 egree relatives or healthy control subjects; first-degree relatives had intermediate enlargement comp
111     Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabe
112     The POCT was found to be positive in 8/9 first-degree relatives having coeliac-type mucosal lesio
113 tients with hypoplastic left heart and their first-degree relatives identified 5 individuals with rig
114                   Cascade genetic testing in first-degree relatives identified 6 additional individua
115  time period of migration and not having any first-degree relatives in Sweden at the time of immigrat
116 asia was detected in 33 (4.2%) and 44 (5.6%) first-degree relatives in the FIT and colonoscopy groups
117  direct contact of relatives, testing beyond first-degree relatives, in-home-based sample collection,
118  774 individuals (the exposed cohort) with a first-degree relative (index case patient) previously ho
119 action was observed regarding the sex of the first-degree relative (interaction P for parents = 0.85;
120 ng as preadolescents; a diagnosis in a child first-degree relative is made in 8% of families screened
121 creening for CRC among surgeons and/or their first-degree relatives is currently not performed at the
122  in our study were sporadic, and the risk to first-degree relatives is lower than previously reported
123                     Cognitive dysfunction in first-degree relatives is more closely related to psycho
124 riteria for serrated polyposis, and in their first-degree relatives, is similar to that of patients d
125                                  Ninety-nine first-degree relatives living within a 100-mile radius o
126 en and families with sudden cardiac death in first-degree relatives &lt;40 years.
127 , and higher rate of sudden cardiac death in first degree relatives&lt;age 30 (4.5% versus 0%, P=0.026).
128                           Three hundred four first-degree relatives (median age, 47 years; age range,
129 y history of pancreatic cancer affecting two first-degree relatives meet criteria for familial pancre
130 of AF was defined as the presence of AF in a first-degree relative: mother, father, sibling, or child
131 0001) and family history of breast cancer in first-degree relatives (n = 7,472; ptrend = 0.0003).
132 itions: bipolar disorder (n = 9), unaffected first-degree relatives (n = 8), and clinical high risk (
133 order (manic, N=110; depressed, N=55), their first-degree relatives (N=316, N=259, N=133, and N=64, r
134 polar disorder with psychosis (N=711), their first-degree relatives (N=883), and demographically comp
135                                The risks for first-degree relatives (odds ratio [OR], 18.69; 95% CI,
136 ks of EoE were significantly increased among first-degree relatives (odds ratio [OR], 7.19; 95% CI, 5
137                          From a total of 634 first degree relatives of 186 biopsy-proven celiac disea
138                    Although it is known that first degree relatives of celiac patients have an increa
139 ly increased risk of breast cancer, untested first-degree relative of a gene mutation carrier, family
140                           A cohort of 57,475 first-degree relatives of 13,922 HL patients diagnosed b
141 % mutation carriers [92% plakophilin-2]; 28% first-degree relatives of a mutation-negative proband).
142 erall lifetime cumulative risk (CR) of HL in first-degree relatives of a patient with HL was 0.6%, wh
143 sed cohort revealed that the rate of EoE, in first-degree relatives of a proband, was 1.8% (unadjuste
144                                              First-degree relatives of ADHD probands were at elevated
145                                              First-degree relatives of adults with psychotic experien
146                                              First-degree relatives of affected individuals have a mo
147 icosteroid-induced ocular hypertension among first-degree relatives of affected individuals support a
148 dentified through cascade genetic testing of first-degree relatives of affected mutation carriers.
149 uals were enrolled in a prospective study of first-degree relatives of ALS and FTD patients carrying
150 on screening should be extended to more than first-degree relatives of an index carrier patient.
151                                        Among first-degree relatives of an index case with factor V Le
152 9 patients with inactive CD and 35 controls (first-degree relatives of and in the same age bracket as
153 on, characteristic of autism, extends to the first-degree relatives of autistic individuals, implying
154  (95% confidence interval [CI] 13.1-22.0) in first-degree relatives of BDI patients, higher than that
155  ORs of BDII were 13.6 (95% CI 10.2-18.2) in first-degree relatives of BDII patients and 9.8 (95% CI
156 ves of schizophrenia probands (n = 264), and first-degree relatives of bipolar disorder I with psycho
157   The prevalence of keratoconus in pediatric first-degree relatives of diagnosed keratoconus patients
158 [OR], 7.19; 95% CI, 5.65-9.14), particularly first-degree relatives of EoE cases diagnosed <18 years
159                    Seventy-five asymptomatic first-degree relatives of FIP patients (mean age, 50.8 y
160             A genetic effect was assessed in first-degree relatives of HS-TLE subjects who did not ha
161 pective, multicentre, observational study of first-degree relatives of individuals carrying the C9orf
162              We analyzed 12-lead ECGs of 401 first-degree relatives of individuals who had died from
163 risk for developing the disorder (unaffected first-degree relatives of individuals with bipolar disor
164                                              First-degree relatives of individuals with T1DM were rec
165 nced fibrosis screening may be considered in first-degree relatives of NAFLD-cirrhosis patients.
166                                              First-degree relatives of NHL, HL, and CLL patients have
167 s in age-matched islet autoantibody-negative first-degree relatives of patients (n = 392; P = 0.00001
168      During an average follow-up of 7 years, first-degree relatives of patients with aortic aneurysm
169                                              First-degree relatives of patients with AVNRT presented
170  by applying the same protocol to 22 healthy first-degree relatives of patients with BD1 and 22 perso
171   The study population comprised 188 healthy first-degree relatives of patients with bipolar disorder
172                                              First-degree relatives of patients with both familial an
173 y is the recommended screening procedure for first-degree relatives of patients with colorectal cance
174                 In a prospective study, 1918 first-degree relatives of patients with CRC were randoml
175 nography is an effective screening method in first-degree relatives of patients with CRC.
176 lonoscopy in detecting advanced neoplasia in first-degree relatives of patients with CRC.
177 gitudinal cohort of self-reported unaffected first-degree relatives of patients with familial interst
178                                    Pediatric first-degree relatives of patients with keratoconus.
179                                        While first-degree relatives of patients with MM show an incre
180             The risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fat
181 nts determined to be at high risk, including first-degree relatives of patients with pancreas cancer
182  may be present in greater than 1 in 6 older first-degree relatives of patients with PF.
183          We assessed the risk for VTE in 915 first-degree relatives of patients with provoked VTE, co
184 th FPF and sporadic IPF.Methods: Undiagnosed first-degree relatives of patients with pulmonary fibros
185  relative-control sample, 58 were unaffected first-degree relatives of patients with schizophrenia (m
186                    We examined 58 unaffected first-degree relatives of patients with schizophrenia an
187 renia who were taking medication, 23 healthy first-degree relatives of patients with schizophrenia, a
188                               In this study, first-degree relatives of patients with SCZ and their re
189 evious studies have reported that unaffected first-degree relatives of patients with SCZ demonstrate
190                                              First-degree relatives of patients with SCZ showed signi
191 ted by the presence of cognitive deficits in first-degree relatives of patients with SCZ; however, un
192 ked VTE, compared this with the risk in 1752 first-degree relatives of patients with unprovoked VTE,
193                              When counseling first-degree relatives of patients with venous thromboem
194 ired from 25 patients with schizophrenia, 25 first-degree relatives of patients, and 29 healthy volun
195 s of SZ probands (SZREL), and 206 unaffected first-degree relatives of PBP probands to identify DMNs
196 MS) project is a prospective cohort study of first-degree relatives of people with MS.
197 ols, the odds of advanced fibrosis among the first-degree relatives of probands with NAFLD-cirrhosis
198       The prevalence of advanced fibrosis in first-degree relatives of probands with NAFLD-cirrhosis
199 otyped familial cohort, we demonstrated that first-degree relatives of probands with NAFLD-cirrhosis
200 vely assess the risk of advanced fibrosis in first-degree relatives of probands with NAFLD-cirrhosis.
201 Z (n = 229) and BDP (n = 188), HP (n = 284), first-degree relatives of schizophrenia probands (n = 26
202                        A total of 54 healthy first-degree relatives of schizophrenic patients and 80
203                                      Healthy first-degree relatives of schizophrenic patients show al
204     No differences were demonstrated between first-degree relatives of SCZ patients and healthy subje
205            Five percent of our patients were first-degree relatives of subjects with CD, with HLA-DQ
206 Z probands, 300 PBP probands, 179 unaffected first-degree relatives of SZ probands (SZREL), and 206 u
207                                In our model, first-degree relatives of the patients with detected PTE
208 an American and 76.3% were white; 76.1% were first-degree relatives of their recipient.
209 RC also did not differ significantly between first-degree relatives of these groups (serrated polypos
210 lsive disorder (OCD) patients, 18 unaffected first-degree relatives of these OCD patients and 49 heal
211 Z or schizoaffective disorder, 30 unaffected first-degree relatives of these SCZ patients, 13 obsessi
212 veloping aortic aneurysm or dissection among first-degree relatives of those with aortic aneurysm or
213                                     Finally, first-degree relatives of those with DS shared volume ab
214                   We examined IA-2var AAb in first-degree relatives of type 1 diabetes (T1D) probands
215 c screening revealed abnormalities in 30% of first-degree relatives of UCA or sudden unexplained deat
216 ion Fraction Registry prospectively assessed first-degree relatives of UCA or sudden unexplained deat
217 f B-cell lymphoproliferative disorders among first-degree relatives of WM patients, has been reported
218 gnificantly larger in probands compared with first-degree relatives or healthy control subjects; firs
219 icantly with breast cancer in the proband or first-degree relative (P < .01), and with colorectal can
220 and with colorectal cancer in the proband or first-degree relative (P < .01), but not family history
221 from recent-onset patients and GADA-positive first-degree relatives participating in the Bart's-Oxfor
222 234 psychotic bipolar (PBP) probands and 231 first-degree relatives (PBPR), and 200 healthy control s
223 r whether these abnormalities are present in first-degree relatives, possibly representing genetic pr
224 %, 87.4%, and 91.0% for third-, second-, and first-degree relatives, respectively).
225 ata revealed no difference in mean number of first-degree relatives screened between nonfamilial and
226 ore cost-effective given that the decedent's first-degree relatives should only need minimal cardiolo
227              Compared with controls, healthy first-degree relatives showed a highly significant decre
228 S aureus bacteremia was observed among these first-degree relatives (SIR, 2.49 [95% CI, 1.95 to 3.19]
229  eosinophilic esophagitis (EoE) mostly among first-degree relatives, suggesting a genetic contributio
230 bsessive-compulsive disorder (OCD) and their first-degree relatives, suggesting involvement of the fr
231 of results between SDIs and their unaffected first-degree relatives, suggesting that the proposed end
232 of other common cardiovascular conditions in first-degree relatives, supporting the use of systematic
233 s, and second-degree relatives of a deceased first-degree relative suspected of having an inherited c
234 esting state EEGs of 225 SZ probands and 201 first-degree relatives (SZR), 234 psychotic bipolar (PBP
235 individual ADs was consistently higher among first-degree relatives than among second- and third-degr
236 o do not have Parkinson's disease but have a first degree relative that does), and 1.4 million contro
237 ounders, infants of mothers who had lost any first-degree relative the year before or during pregnanc
238 sed 100-fold; given >/=2 premature deaths in first-degree relatives, the rate increased more than 400
239  complete ANGPTL3 deficiency and 3 wild-type first-degree relatives using computed tomography angiogr
240 rates approached 1 per 1000 person-years for first-degree relatives versus 11 to 13 (aortic aneurysm)
241 ct contact (2.06 versus 0.86), tested beyond first-degree relatives versus only first-degree relative
242 ere at risk of carrying a mutation because a first-degree relative was a known symptomatic carrier.
243                    A family history of AD in first-degree relatives was associated with an RR of 6.82
244                          The risk for VTE in first-degree relatives was higher if the index cases had
245 Using prospectively registered data on their first-degree relatives, we evaluated the impact of paren
246 ives (5.4%), increasing to 7% (6/85) if only first-degree relatives were assessed.
247 % male) who had received a diagnosis of CUP, first-degree relatives were at an elevated risk of CUP t
248      The lifetime risk of HL was higher when first-degree relatives were diagnosed at early ages (bef
249                 A total of 10 of 99 (10.10%) first-degree relatives were diagnosed with PDS (1 with P
250                                    Available first-degree relatives were invited to undergo noncathar
251 s aged below 50 years, high-volume surgeons' first-degree relatives were more likely to be up-to-date
252                    All remaining 135 healthy first-degree relatives were negative for both POCT and E
253 ree relatives and 8% of anti-CCP-2- negative first-degree relatives were positive for >/=9 ACPAs.
254                                              First-degree relatives were submitted to cardiac screeni
255                                        Their first-degree relatives were unaffected.
256 years reported that 56.1% (n = 210) of their first-degree relatives were up-to-date with CRC screenin
257 ree relative with PCa (FH); and those with a first-degree relative who had died of PCa (FHD).
258 ontrol subjects with tetramer(+) cells was a first-degree relative who had insulin-specific cells wit
259 undergoing radical prostatectomy, those with first-degree relatives who died of PCa did not have an i
260 lepsy from 1935-94 (probands) and their 2439 first-degree relatives who resided in Olmsted County.
261 uated, and those who agreed to contact their first-degree relatives who were at least 40 years old we
262 sotypes), and sera from 99 antibody-negative first-degree relatives who were never autoantibody posit
263  mutation that results in AD and 115 (38.5%) first-degree relatives who were noncarrier controls.
264 ate ACPAs in sera from 111 antibody-positive first-degree relatives who were positive on at least 1 v
265 ion and of new cases of celiac disease among first degree relatives with negative results at a first
266                           Eight patients had first degree relatives with visual snow.
267  controlled trial in infants with at least 1 first-degree relative with allergic disease.
268 .82 x 10(-7)) and were more likely to have a first-degree relative with AMD (P = 5.38 x 10(-6)).
269 8 939 individuals (mean age, 42 years) had a first-degree relative with aortic aneurysm and 7209 pers
270  and 7209 persons (mean age, 39 years) had a first-degree relative with aortic dissection.
271 rticipants, 71 individuals with at least one first-degree relative with BD (at-risk), and 80 control
272 iduals aged 18 to 30 years with at least one first-degree relative with bipolar disorder were compare
273 tion task: 24 with BP, 29 at risk based on a first-degree relative with BP, and 53 healthy, low-risk
274  was 1.3-fold higher for HL survivors with a first-degree relative with cancer ( P < .001), with 3.3-
275  We randomly assigned 832 newborns who had a first-degree relative with celiac disease to the introdu
276  for HLA-DQ2 or HLA-DQ8 and had at least one first-degree relative with celiac disease.
277 iduals between ages 45 and 65 years with one first-degree relative with CRC age < 50 years or two fir
278 ers of monoallelic mutations in MUTYH with a first-degree relative with CRC are sufficiently high to
279 r monoallelic MUTYH mutation carriers with a first-degree relative with CRC diagnosed by 50 years of
280      Of 430 young CRC cases, 111 (26%) had a first-degree relative with CRC.
281 nors with (n = 1245) vs. without (n = 757) a first-degree relative with ESRD.
282  implantations), individuals with at least 1 first-degree relative with history of pacemaker insertio
283 men), and 94 were healthy controls without a first-degree relative with mental illness (mean [SD] age
284  risk of developing eczema (ie, at least one first-degree relative with parent-reported eczema, aller
285 o men with no family history of PCa (NFH); a first-degree relative with PCa (FH); and those with a fi
286 om the general population and those having a first-degree relative with T1D were enrolled if they had
287 ctively), adjusting for the HLA-DR genotype, first-degree relative with T1DM, maternal education, and
288 h HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited fro
289 ilial adenomatous polyposis), or one or more first-degree relatives with a history of thyroid cancer.
290 n 1 year of age at high risk of atopy (>/= 2 first-degree relatives with allergic disease) but with n
291 tratified by recruiting centre and number of first-degree relatives with atopic disease) and particip
292 ts from our institution, of whom 20 had >/=1 first-degree relatives with AVNRT.
293 ; RR, 2.5; 95% CI, 1.1 to 5.3) or women with first-degree relatives with bilateral disease (RR, 3.6;
294 95% CI, 50 to 66) for those with two or more first-degree relatives with breast cancer at 50 years of
295 a of any size, or an adenoma of any size and first-degree relatives with colorectal cancer.
296 gree relative with CRC age < 50 years or two first-degree relatives with CRC were selected.
297 athogenic mutations of the RET gene, or were first-degree relatives with histologically proven medull
298 A gene mutation, and patients with 1 or more first-degree relatives with pancreas cancer with Lynch s
299 n a first-degree relative age <60 years or 2 first-degree relatives with these findings at any age ar
300             Serum samples were obtained from first-degree relatives without RA according to the 1987

 
Page Top